• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Tuesday, March 28, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Scientists show how gene expression controls synaptic plasticity in the aging human brain

Bioengineer by Bioengineer
March 8, 2023
in Health
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Scientific evidence shows how the cognitive decline in Alzheimer’s disease (AD) is caused by the buildup of amyloid beta proteins, which promote synaptic malfunction. One of the neuropathological features in the brains of patients with AD is the degeneration of the basal forebrain cholinergic neurons, leading to a decrease in the number of cholinergic projections to the hippocampus. As a symptomatic treatment of AD, cholinergic neurotransmission is enhanced by the use of certain drugs, known as acetylcholinesterase inhibitors. For better prevention and treatment of cognitive disorders like AD and schizophrenia, it is necessary to understand how acetylcholine regulates synaptic transmissions.

AMPAR trafficking pathway for long term potentiation and differentiation in Alzhiemer’s disease animal models

Credit: Tomonari Sumi and Kouji Harada from Okayama University

Scientific evidence shows how the cognitive decline in Alzheimer’s disease (AD) is caused by the buildup of amyloid beta proteins, which promote synaptic malfunction. One of the neuropathological features in the brains of patients with AD is the degeneration of the basal forebrain cholinergic neurons, leading to a decrease in the number of cholinergic projections to the hippocampus. As a symptomatic treatment of AD, cholinergic neurotransmission is enhanced by the use of certain drugs, known as acetylcholinesterase inhibitors. For better prevention and treatment of cognitive disorders like AD and schizophrenia, it is necessary to understand how acetylcholine regulates synaptic transmissions.

 

Higher brain functions, like learning and memory, are partly regulated by signaling through the M1 muscarinic acetylcholine receptor (mAChR). The mAChR also induces long-term potentiation (LTP) and long-term depression (LTD) of excitatory synaptic transmission in the hippocampus. During hippocampus-controlled learning activities, extracellular levels of acetylcholine (Ach) increase by 4 times in the hippocampus, driven by mAChR signal transmission. Activation of the mAChR by agonists (activator chemicals) is known to induce LTP and LTD in the hippocampus, but the underlying molecular mechanisms are not well understood.

 

To study these molecular mechanisms, scientists from Japan have recently designed a model to track hippocampal synaptic plasticity. Their study has been published in volume 26 issue 3 of iScience on 17 March, 2023 (first published online on 3 February 2023).  

 

Associate Professor Tomonari Sumi from Okayama University, Japan, who led the study, explains, “Here, we propose the hypothesis that M1 mAChR-dependent LTP and LTD share the common a-amino-3-hydroxy5-methyl-4-isoxazolepropionic acid receptor (AMPAR) trafficking pathway associated with NMDAR dependent LTP and LTD.” For the hippocampal neurons, an AMPA receptor (AMPAR) trafficking model was proposed to simulate N-methyl-D-aspartate receptor (NMDAR)-dependent synaptic plasticity. The findings of this study prove the validity of the hypothesis that the mAChR-dependent LTP and LTD share a common AMPAR trafficking pathway.

 

The difference between the two pathways is that in the M1-mAChR activation, Ca2+ ions stored in the endoplasmic reticulum of the neurons are released into the spine cytosol. A competition between Ca2+ dependent exocytosis and endocytosis regulates LTP and LPD.  “Therefore, it can be concluded that the M1 mAChR-dependent induction of LTP and LTD shares the common AMPAR trafficking pathway with NMDAR-dependent synaptic plasticity, and new gene expression is not necessary, at least in the early stages of LTP and LTD.” says Kouji Harada from the Center for IT-Based Education, Toyohashi University of Technology.

 

These findings show how the reduction in the number of AMPARs due to varying gene expression levels affects the induction of LTP and LTD. These results will be useful to understand the dominant factors resulting in alterations of LTP and LTD in animal models of AD, which can ultimately be greatly helpful for the development of AD therapy targeting synaptic plasticity for humans.

 

Aging of the human brain causes a marked reduction in the expression of a number of neurotransmitter receptors, like GluA1, which induces the integration of AMPA receptors inside synaptic membranes. The AMPAR trafficking model shows that alterations in LTP and LTD observed in AD could be due to age-related reduction in AMPAR expression levels. “Taken together, these observations suggest that either upregulation of neurotransmitter receptor genes or suppression of the downregulation could improve synaptic dysfunction during AD.” says Dr. Sumi.

 

About Okayama University, Japan

As one of the leading universities in Japan, Okayama University aims to create and establish a new paradigm for the sustainable development of the world. Okayama University offers a wide range of academic fields, which become the basis of the integrated graduate schools. This not only allows us to conduct the most advanced and up-to-date research, but also provides an enriching educational experience.

Website: https://www.okayama-u.ac.jp/index_e.html

 

About Associate Professor Tomonari Sumi from Okayama University, Japan

Dr. Tomonari Sumi is an Associate Professor at the Research Institute for Interdisciplinary Science at Okayama University, Japan. He holds a Doctor of Engineering degree and has 75 publications, mostly in areas like Molecular Dynamics, Computational Chemistry, Quantum Chemistry and Statistical thermodynamics.



Journal

iScience

DOI

10.1016/j.isci.2023.106133

Method of Research

Experimental study

Subject of Research

Animals

Article Title

Muscarinic acetylcholine receptor-dependent and NMDA receptor-dependent LTP and LTD share the common AMPAR trafficking pathway

Article Publication Date

17-Mar-2023

Share12Tweet8Share2ShareShareShare2

Related Posts

Instructor teaching a health class

Implementation of school-based wellbeing programs benefits from multiple voices

March 27, 2023
McMaster researchers trial primary care program for older adults

McMaster researchers trial primary care program for older adults

March 27, 2023

JNM explores potential applications for ChatGPT in nuclear medicine and molecular imaging

March 27, 2023

Study finds neighborhood apps increase perceptions of crime rates

March 27, 2023

POPULAR NEWS

  • ChatPandaGPT

    Insilico Medicine brings AI-powered “ChatPandaGPT” to its target discovery platform

    66 shares
    Share 26 Tweet 17
  • Northern and southern resident orcas hunt differently, which may help explain the decline of southern orcas

    44 shares
    Share 18 Tweet 11
  • Skipping breakfast may compromise the immune system

    43 shares
    Share 17 Tweet 11
  • Insular dwarfs and giants more likely to go extinct

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

ISTA welcomes first journalists in residence

Candidate found to inhibit malignant melanoma growth

Cancer that spreads to the lung maneuvers to avoid being attacked by “killer” T cells

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 48 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In